Mechanism of Action: Cytochrome P450 2C8 Inhibitors
✉ Email this page to a colleague
Drugs with Mechanism of Action: Cytochrome P450 2C8 Inhibitors
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Msn | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 210686-001 | Jul 10, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Rising | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 208371-001 | Feb 25, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Qilu | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 212462-001 | Sep 27, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Teva Pharms Usa | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 208432-001 | Oct 31, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |